Status:

RECRUITING

Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis

Lead Sponsor:

Medipol University

Conditions:

Endometriosis

Eligibility:

FEMALE

20-50 years

Phase:

NA

Brief Summary

The aim of our study is to investigate the effects of pelvic floor muscle strengthening exercises with EMG-Biofeedback and pelvic floor muscle strengthening exercises with Rebound therapy on pelvic fl...

Detailed Description

Endometriosis is a chronic, systematic, inflammatory, estrogen-dependent public health problem characterized by the growth of endometrial-like tissue outside the uterine cavity, including the pelvic p...

Eligibility Criteria

Inclusion

  • Being between 20-50 years old,
  • Being diagnosed with endometriosis,
  • Completing the voluntary consent form,
  • Pain level being at least 4 on the Visual Analog Scale (VAS).

Exclusion

  • Exclusion Criteria for the EMG-Biofeedback Group:
  • Being included in another study during the study period,
  • Being receiving medical treatment for endometriosis,
  • Presence of gynecological bleeding,
  • Presence of communication and cooperation problems,
  • Presence of tubo-ovarian abscess,
  • Active vaginal or urinary tract infection,
  • Pregnancy and giving birth within the last 12 months,
  • Presence of impaired somatosensory status,
  • Not attending 2 consecutive sessions.
  • Exclusion Criteria for the Rebound Therapy Group:
  • In addition to the exclusion criteria determined for the EMG-Biofeedback Group;
  • Presence of a neurological or orthopedic disease affecting the lower extremity,
  • History of spine and/or lower extremity orthopedic surgery,
  • Presence of severe arthritis affecting the spine and/or lower extremity,
  • Presence of uncontrolled hypertension and cardiovascular disease.

Key Trial Info

Start Date :

September 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2025

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT06517654

Start Date

September 1 2024

End Date

September 1 2025

Last Update

February 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zeynep Kamil Women and Children's Diseases Training and Research Hospital

Üsküdar, Istanbul, Turkey (Türkiye), 34668